We participate in transformative health research initiatives that address real needs and contribute to improve health outcomes.
Active Projects
ERDERA
Budget: €385.5M (Co-funded by Horizon EU)
Duration: 2024-2031
Participants: +180 organisations & 36 countries
Coordinator: INSERM
Learn more
Duration: 2024-2031
Participants: +180 organisations & 36 countries
Coordinator: INSERM
UMBRELLA
Budget: €26.9M (€14.8M from Innovative Health Initiative and €12.1M from Industry Partners)
Duration: 2024-2029
Participants: 30 organisations
Coordinator: Vall d’Hebron Research Institute (VHIR) and Siemens Healthineers
Learn more
Duration: 2024-2029
Participants: 30 organisations
Coordinator: Vall d’Hebron Research Institute (VHIR) and Siemens Healthineers
RealiseD
Budget: €17M
Duration: 2025-2029
Participants: 38 organisations
Coordinator: Sigmund Freud Private University and AstraZeneca
Learn more
Duration: 2025-2029
Participants: 38 organisations
Coordinator: Sigmund Freud Private University and AstraZeneca
WIDEnzymes
Budget: €1.2M (Horizon Widera 2023 Access 04)
Duration: 2024-2027
Participants: 5 partners
Coordinator: Latvian Institute of Organic Syntesis
Learn more
Duration: 2024-2027
Participants: 5 partners
Coordinator: Latvian Institute of Organic Syntesis
FIBROTARGET
Budget: €5.68M (Horizon Europe Research and Innovation Action Funding Programme)
Duration: 2023-2028
Participants: 8 partners
Coordinator: KU Leuven (University of Leuven)
Learn more
Duration: 2023-2028
Participants: 8 partners
Coordinator: KU Leuven (University of Leuven)
REMEDI4ALL
Budget: €23M
(Horizon Europe Research and Innovation Action Funding Programme)
Duration: 2022-2027
Participants: 24 partners
Coordinator: EATRIS
Learn more
Duration: 2022-2027
Participants: 24 partners
Coordinator: EATRIS
H2O
Budget: €20.4M (IMI funding programme)
Duration: 2020-2025
Participants: 23 partners
Coordinator: Medizinische Univesität Wien & Takeda Pharmaceuticals
Learn more
Duration: 2020-2025
Participants: 23 partners
Coordinator: Medizinische Univesität Wien & Takeda Pharmaceuticals
PREMIER
Budget: €9M (IMI funding programme)
Duration: 2020-2026
Participants: 25 partners
Coordinator: Radboud University Nijmegen
Learn more
Duration: 2020-2026
Participants: 25 partners
Coordinator: Radboud University Nijmegen
PHOTOTHERAPORT
Budget: €3M (Horizon EIC Grants)
Duration: 2024-2026
Participants: 8 partners
Coordinator: Fundació Institut de Bioenginyeria de Catalunya (IBEC)
Learn more
Duration: 2024-2026
Participants: 8 partners
Coordinator: Fundació Institut de Bioenginyeria de Catalunya (IBEC)
Closed Projects
PROMISE
Budget: 7.024.387€
Duration: 30 months
Participants: 22 partners
Coordinator: UEDIN & UMCU
Learn more
Duration: 30 months
Participants: 22 partners
Coordinator: UEDIN & UMCU
PARADIGM
Budget: €9.1M (IMI funding programme)
Duration: 2018-2020
Participants: 34 partners
Coordinator: Forum Europeen Des Patients (EPF)
Duration: 2018-2020
Participants: 34 partners
Coordinator: Forum Europeen Des Patients (EPF)
RESCEU
Budget: €25M (IMI funding programme)
Duration: 2017-2021
Participants: 18 partners
Coordinator: University of Edinburgh
Learn more
Duration: 2017-2021
Participants: 18 partners
Coordinator: University of Edinburgh
EU-PEARL
Budget:€29M (IMI funding programme)
Duration: 2019-2023
Participants: 36 partners
Coordinator: Vall d’Hebron Research Institute (VHIR)
Learn more
Duration: 2019-2023
Participants: 36 partners
Coordinator: Vall d’Hebron Research Institute (VHIR)
Members of our team have previously been involved in:
Accelerated development of vaccine benefit-risk collaboration in Europe
Arrhythmogenic potential of drugs
European Medical Information Framework
Integrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicities
Learn more
Genotype-to-Phenotype Databases: A Holistic Solution
AIDS vaccine research project
European Prevention of Alzheimer’s Dementia
Promoting and Monitoring Biomedica Informatics in Europe
Intelligence-led Assessment of Pharmaceuticlas in the Environment
Creating medicaly-driven integrative bioinformatics applications focused on oncology, CNS disorders and biotech companies researching on treatment of neuropathic pain
Strategic alliance between pharmaceutical and biotech companies researching on treatment on neoropathic pain
Safety evaluation on Adverse Reactions in Diabetes
Safety of non-Steroidal anti-inflammatory drugs
